Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis

[1]  M. Ducreux,et al.  Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Baixuan Xu,et al.  Pretreatment Metabolic Parameters Measured by 18F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C , 2022, Frontiers in Oncology.

[3]  R. Bhogal,et al.  The Diagnostic Accuracy of 18 F-FGD-PET/CT for Cancer of the Gallbladder: A Retrospective Study , 2022, World journal of nuclear medicine.

[4]  J. Gallaher,et al.  Acute Cholecystitis: A Review. , 2022, JAMA.

[5]  Jin‐Young Jang,et al.  Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer , 2021, Annals of surgical treatment and research.

[6]  S. Kulaçoğlu,et al.  Xanthogranulomatous Cholecystitis and Gallbladder Cancer: Two Diseases with Difficult Differential Diagnoses. , 2021, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[7]  A. Duffy,et al.  Gallbladder Disorders: A Comprehensive Review. , 2021, Disease-a-month : DM.

[8]  D. Ganeshan,et al.  Current update on gallbladder carcinoma , 2021, Abdominal Radiology.

[9]  A. Iagaru,et al.  The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer. , 2020, Seminars in nuclear medicine.

[10]  H. Park,et al.  Benign gallbladder diseases: Imaging techniques and tips for differentiating with malignant gallbladder diseases , 2020, World journal of gastroenterology.

[11]  S. Maithel,et al.  The Landmark Series: Gallbladder Cancer , 2020, Annals of Surgical Oncology.

[12]  M. Schwartz,et al.  Surgical Treatments of Hepatobiliary Cancers , 2020, Hepatology.

[13]  A. Iqbal,et al.  18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  M. M. Sevinç,et al.  The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[15]  Dexiang Zhang,et al.  Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer. , 2019, Annals of translational medicine.

[16]  C. Contreras,et al.  Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. , 2019, The Surgical clinics of North America.

[17]  F. Alemi,et al.  Gallstone Disease: Cholecystitis, Mirizzi Syndrome, Bouveret Syndrome, Gallstone Ileus. , 2019, The Surgical clinics of North America.

[18]  Nai-Ming Cheng,et al.  Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma , 2018, Clinical nuclear medicine.

[19]  N. Kalra,et al.  Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening , 2018, Journal of Gastrointestinal Cancer.

[20]  Cyril Ferdynus,et al.  Decision curve analysis: a technical note. , 2018, Annals of translational medicine.

[21]  Lisa M Rowley,et al.  Harmonizing standardized uptake value recovery between two PET/CT systems from different manufacturers when using resolution modelling and time-of-flight , 2017, Nuclear medicine communications.

[22]  Christine S. M. Lau,et al.  Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973–2013) , 2017, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[23]  F. Ferro,et al.  Gallbladder adenomyomatosis: imaging findings, tricks and pitfalls , 2017, Insights into Imaging.

[24]  Jin You Kim,et al.  Diffusion-weighted magnetic resonance imaging of gallbladder adenocarcinoma: analysis with emphasis on histologic grade. , 2016, Clinical imaging.

[25]  G. Treglia,et al.  Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis. , 2015, World journal of gastroenterology.

[26]  P. Park,et al.  Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis. , 2015, World journal of gastroenterology.

[27]  M. Gönen,et al.  Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. , 2014, Journal of the American College of Surgeons.

[28]  Zhi-Hai Peng,et al.  Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. , 2014, World journal of gastroenterology.

[29]  J. Llamas-Elvira,et al.  Ability of FDG‐PET/CT in the detection of gallbladder cancer , 2014, Journal of surgical oncology.

[30]  E. Shaffer,et al.  Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer , 2012, Gut and liver.

[31]  M. Yun,et al.  Risk Stratification of Gallbladder Polyps (1–2 cm) for Surgical Intervention with 18F-FDG PET/CT , 2012, The Journal of Nuclear Medicine.

[32]  T. Nakahara,et al.  Successful Diagnosis of Gallbladder Carcinoma Coexisting with Adenomyomatosis by 18F-FDG-PET—Report of a Case , 2011, Journal of gastrointestinal cancer.

[33]  F. Pruvot,et al.  Incidental Gallbladder Cancer by the AFC-GBC-2009 Study Group , 2011, World Journal of Surgery.

[34]  M. Meneses,et al.  The role of PET-CT in patients with incidental gallbladder cancer. , 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[35]  Philippe Fernandez,et al.  The Effect of Renal Failure on 18F-FDG Uptake: A Theoretic Assessment , 2008, Journal of Nuclear Medicine Technology.

[36]  M. Choti,et al.  Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection , 2007, Journal of Gastrointestinal Surgery.

[37]  H. Taniguchi,et al.  Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine‐18‐labeled fluoro‐deoxyglucose (FDG‐PET) , 2003, Journal of surgical oncology.

[38]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[39]  G. Butturini,et al.  Incidental carcinoma of the gallbladder. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[40]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[41]  P. Shreve.  Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease , 1998, European Journal of Nuclear Medicine.

[42]  J. Mcnee.  Cholecystitis* , 1937, British medical journal.